Hc Advisors, LLC Bristol Myers Squibb CO Transaction History

Hc Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $21,591 - $24,480	450 Added 5.33%	8,898 $482,000
Q4 2023 Jan 25, 2024	BUY	$48.48 - $57.85 $7,514 - $8,966	155 Added 1.87%	8,448 $433,000
Q3 2023 Nov 07, 2023	BUY	$57.89 - $64.73 $15,340 - $17,153	265 Added 3.3%	8,293 $481,000
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $5,415 - $6,012	85 Added 1.07%	8,028 $513,000
Q1 2023 May 08, 2023	BUY	$65.71 - $74.53 $8,016 - $9,092	122 Added 1.56%	7,943 $550,000
Q4 2022 Feb 08, 2023	BUY	$68.48 - $81.09 $205,440 - $243,270	3,000 Added 62.23%	7,821 $562,000
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $7 - $4,226	-55 Reduced 1.13%	4,821 $343,000
Q2 2022 Aug 08, 2022	SELL	$72.62 - $79.98 $14,160 - $15,596	-195 Reduced 3.85%	4,876 $375,000
Q1 2022 May 06, 2022	BUY	$61.48 - $73.72 $311,765 - $373,834	5,071 New	5,071 $370,000

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Hc Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Hc Advisors, LLC with notifications on news.